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Abstract Trypanosome alternative oxidase (TAO) is the ter-
minal oxidase of the respiratory chain in long slender blood-
stream forms of African trypanosomes. TAO is a cytochrome-
independent, cyanide-insensitive quinol oxidase. These charac-
teristics are distinct from those of the bacterial quinol oxidases,
proteins that belong to the heme-copper terminal oxidase super-
family. The inability to purify stable TAO has severely ham-
pered biochemical studies of the alternative oxidase family. In
the present study, we were able to purify recombinant TAO to
homogeneity from Escherichia coli membranes using the deter-
gent digitonin. Kinetic analysis of the puri¢ed TAO revealed
that the speci¢c inhibitor ascofuranone is a competitive inhibitor
of ubiquinol oxidase activity.
# 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
African trypanosome is a parasite that causes African sleep-
ing sickness in humans and Nagana disease in cattle. Because
current drugs against trypanosomes have strong side e¡ects
and are not e¡ective for chronic phase patients, new drugs are
needed. We have found that the antibiotic ascofuranone (Fig.
1) strongly inhibits the glycerol-3-phosphate (G3P)-dependent
mitochondrial oxygen consumption by the bloodstream form
of Trypanosoma brucei brucei. The G3P oxidase system is
composed of G3P dehydrogenase, ubiquinone and cyanide-
insensitive ubiquinol oxidase, also known as the trypanosome
alternative oxidase (TAO) (see [1] for review). This respiratory
system is essential for survival of the bloodstream form of the
parasite because it reoxidizes reducing equivalents produced
during glycolysis in the glycosome. Ascofuranone, isolated
from the phytopathogenic fungus Ascochyta visiae, speci¢cally
inhibits the quinol oxidase activity of TAO in the mitochon-
dria [2,3]. Since TAO does not occur in the mammalian host,
it has been targeted for anti-trypanosomal chemotherapy
[1,4].
TAO is a member of the cyanide-insensitive alternative ox-
idases (AOXs), which have been found in higher plants, algae,
yeast, slime molds and free-living amoebae [5^7]. The ubiqui-
tous presence of these enzymes suggests that AOXs have a
general physiological role, including maintenance of the cel-
lular redox balance and protection against oxidative stress
(see [8] for a review). Like AOXs, the heme-containing termi-
nal oxidases, such as cytochrome c oxidase, catalyze the four-
electron reduction of oxygen to form water. However, AOXs
do not translocate protons, allowing electron transfer to pro-
ceed without coupling to ATP synthesis. Spectroscopic studies
of the partially puri¢ed enzyme indicate that AOXs are also
distinct because they do not contain a heme or an iron^sulfur
center [8]. Despite this lack of a heme or an iron^sulfur center,
studies in the fungus Pichia anomala (formerly Hancenula
anomana)[9] and T. brucei brucei [10] show that the enzyme
activity requires iron. This iron binding may be contributed
by the conserved sequence motif of AOXs, -E (D)- and
-EXXH-, which is similar to the binuclear iron binding se-
quences of the hydroxylase enzymes ribonucleotide reductase
R2, methane monooxygenase and v9-desaturase [11]. Finally,
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Fig. 1. Structures of ubiquinol and ascofuranone.
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the structure and membrane-inserted portions of AOX has
been predicted from amino acid sequences of the enzyme
[12,13], but biochemical validation has not been available be-
cause of the lack of pure protein.
The cDNA for TAO has been cloned and characterized,
and TAO has been veri¢ed as a member of the AOX family
[14,15]. To study the molecular properties of TAO and the
mechanisms of the trypanocide ascofuranone, large-scale pu-
ri¢cation of active enzyme is essential. However, similar to
other AOXs, puri¢cation of TAO from T. brucei brucei is
di⁄cult because the enzyme is unstable when solubilized
from the mitochondrial membrane [16]. To overcome this
problem, the recombinant enzyme must be produced by bac-
terial overexpression. Such a system has not yet been estab-
lished, although recombinant TAO (rTAO) has been ex-
pressed in Escherichia coli [14,15]. As pointed out by
A¡ourtit and coworkers, the lack of a stable fully puri¢ed
enzyme has severely hampered biochemical studies of AOX
family [8]. In addition, the ubiquinol oxidase activity of E. coli
terminal oxidases (cytochrome bo and bd complexes) interferes
with the kinetic analysis of rTAO [15,17].
In the present study, we expressed rTAO in the E. coli
vhemA mutant FN102/pTAO. The rTAO was puri¢ed to
homogeneity from the E. coli membrane using the detergent
digitonin. Kinetic analysis of the puri¢ed enzyme revealed
that ascofuranone is a competitive inhibitor vs. the substrate
ubiquinol.
2. Materials and methods
2.1. Establishment of overproduction system for rTAO in E. coli
To obtain the heme-de¢cient host strain for the expression of
rTAO, the vhemA : :KmR mutation [18] was introduced into the strain
BL21(DE3) by P1 transduction. The FN102 heme-de¢cient strain was
then transformed using expression vector pTAO, which carries the
cDNA for TAO isolated from T. brucei brucei TC221 [15,17]. Ampi-
cillin (100 Wg/ml) and kanamycin (50 Wg/ml) were used to select
rTAO-expressing cells.
2.2. Membrane preparation
The strain FN102/pTAO was grown aerobically at 30‡C in 10 l of
medium containing 104 g K2HPO4, 30 g KH2PO4, 7.5 g Na-citrate
2H2O, 25 g (NH4)2SO4, 100 g tryptone peptone, 50 g yeast extract,
50 g casamino acids, 0.5 g MgSO4W7H2O, 0.25 g FeSO4W7H2O, 2 g
glucose and 100 mg ampicillin. Expression of rTAO was induced by
the addition of IPTG (100 WM) when the bacterial culture reached 0.1
absorbance units at OD550. The cells were collected after 3 h of culture
and resuspended in 60 mM Tris^HCl (pH 7.5), broken by French
Pressure Cell (Ohtake, Tokyo) and centrifuged at 27 000Ug for 15
min (TOMY MRX-150). The cytosolic supernatant was separated
into cytoplasm and a membrane pellet by further centrifugation at
200 000Ug for 1 h (Hitachi CS120). The membrane pellet was resus-
pended in 60 mM Tris^HCl (pH 7.5) and used as the membrane
sample.
2.3. Solubilization and puri¢cation of rTAO
To ¢nd a detergent which solubilizes active rTAO, membrane con-
taining rTAO was incubated with various detergents (1 mg/ml of
protein in 60 mM Tris^HCl, pH 7.5) for 1 h at 4‡C and centrifuged
at 200 000Ug for 1 h (HITACHI CS120). The quinol oxidase activ-
ities of the samples before centrifugation, as well as of supernatant
and pellet were determined.
For the puri¢cation of rTAO, membrane was treated with 3% (w/v)
digitonin (1 mg/ml of protein in 60 mM Tris^HCl, pH 7.5) at 4‡C for
1 h. After centrifugation at 200 000Ug for 1 h, the supernatant was
applied to a nickel column (2 ml). The column was washed with
water, treated with 50 mM NiSO4, then equilibrated with binding
bu¡er containing digitonin (5 mM imidazole, 0.5 M NaCl, 20 mM
NaCl, 20 mM Tris^HCl, pH 7.5, 1% (w/v) digitonin). His-tagged
rTAO was diluted by 8U binding bu¡er to a ¢nal concentration of
1U and applied to the column, then was eluted with a gradient of 5^
250 mM imidazole (1.3 mM imidazole/min; £ow rate 0.3 ml/min) in
20 mM Tris^HCl (pH 7.5) and 1% (w/v) digitonin.
2.4. Assay of ubiquinol oxidase
Ubiquinol oxidase activity was determined by measuring the absor-
bance change of ubiquinol-1 at 278 nm (Shimadzu spectrophotometer
UV-3000) [19]. The reaction was initiated with the addition of a mem-
brane sample to a mixture containing 60 mM Tris^HCl (pH 7.5),
0.01% (w/v) digitonin and 150 WM of ubiquinol-1 (millimolar extinc-
tion coe⁄cient of 15 for ubiquinone-1) at 25‡C.
2.5. Chemicals
All detergents were purchased from Dojin Chemicals (Tokyo, Ja-
pan). Digitonin used in this study was biochemistry grade with highest
purity. Ubiquinone-1 was purchased from Sigma.
3. Results and discussion
3.1. Overproduction of rTAO
To remove the quinol oxidase activity of heme-containing
cytochrome bo and bd complexes from the host strain, the
vhemA : :KmR mutation [18] was introduced into strain
BL21(DE3) by P1 transduction. Because the hemA-de¢cient
mutant lacks glutamyl-tRNA reductase needed to catalyze the
¢rst step of heme synthesis, the mutant does not grow aerobi-
cally in the absence of 5-aminolevulinic acid (ALA), a precur-
sor for protoheme IX synthesis. However, the FN102 heme-
de¢cient strain containing the pTAO plasmid, which contains
the cDNA for TAO from T. brucei brucei TC221 [15,17],
showed similar aerobic growth to wild-type even in the ab-
sence of ALA. This indicates that rTAO functions as a ter-
minal oxidase in the respiratory chain of E. coli. Finally, to
simplify puri¢cation of rTAO, we introduced a histidine-tag
to the amino terminus of rTAO [15].
When the cells were grown at 37‡C, rTAO was produced in
inclusion bodies and had no ubiquinol oxidase activity. For
this reason, screening of culture conditions was necessary to
Fig. 2. SDS^PAGE of rTAO. The E. coli hemA-mutant was grown
as described in Section 2 in the presence of 100 WM IPTG. 5 Wg of
protein was loaded onto each lane of a 12.5% (w/v) SDS^PAGE.
Lane 1, marker; lane 2, membrane from FN102/pET; lane 3, mem-
brane from FN102/pTAO; lane 4, supernatant solubilized from the
membrane by digitonin; lane 5, precipitate after solubilization by
digitonin.
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establish a system for expressing large quantities active rTAO.
After extensive testing, we identi¢ed optimal conditions for
large-scale culture in volumes of more than 10 l (see Section
2). Under these conditions, rTAO accounted for more than
80% of the total membrane protein (Fig. 2, lane 3). The spe-
ci¢c activity of ubiquinol oxidase (approximately 5 Wmol/min/
mg) in the membrane from FN102/pTAO was similar to that
of the membrane from the wild-type strain (hemAþ), which
contains cytochrome bo and bd complexes [19,20]. As ex-
pected, there was no ubiquinol oxidase activity in the mem-
brane from the FN102 heme-de¢cient strain.
3.2. Solubilization and puri¢cation of rTAO
We ¢rst examined the ability of 20 detergents to extract
active TAO. Only digitonin, a non-ionic detergent, solubilized
a functional TAO from the membranes of FN102/pTAO cells.
Other detergents that have been reported to solubilize AOXs
from plant mitochondria, including deoxycholate, BIGCHAP,
deoxyBIGCHAP and taurocholate [21^25], were much less
e¡ective than digitonin. Some detergents, such as sarcosyl,
were able to solubilize TAO but were unable to maintain its
quinol oxidase activity. Therefore, we used digitonin for fur-
ther puri¢cation of rTAO.
Fig. 3. Puri¢cation of rTAO. A: Elution pattern of rTAO from nickel column. The supernatant, solubilized from the cytoplasmic membrane
fraction of E. coli with 3% (w/v) digitonin, was applied to a nickel column. His-tagged rTAO bound to the nickel column was eluted with a
gradient of 5^250 mM imidazole (1.3 mM imidazole/min; £ow rate 0.3 ml/min) in 20 mM Tris^HCl (pH 7.5) and 1% (w/v) digitonin.
B: 12.5% SDS^PAGE of eluted fractions from nickel column chromatography. Each 850 Wl of digitonin-extract and £ow through fraction
(lanes 1 and 2) were concentrated by trichloroacetate precipitation prior to loading on the gel. Similarly, each 160 Wl of eluted fractions 15^20
(lane 3^8) was concentrated by trichloroacetate precipitation prior to loading on the gel. After SDS^PAGE, the gel was stained with Coomassie
brilliant blue. The arrow indicates rTAO with an apparent molecular mass of 34 kDa. C: SDS^PAGE and Western blot of puri¢ed rTAO ob-
tained by rechromatography of nickel column. Antibody against highly puri¢ed rTAO obtained by nickel column in the presence of guanidine
was used. Epitope recognized by this antibody was C-terminal domain of the enzyme. Same result was observed when antibody against plant
AOX [23] was used (data not shown).
FEBS 27016 28-2-03
C. Nihei et al./FEBS Letters 538 (2003) 35^40 37
Although the speci¢c activity of rTAO was decreased and a
signi¢cant amount of rTAO remained in the membrane dur-
ing solubilization (Fig. 2, lane 5), about 17% of the membrane
ubiquinol oxidase activity was solubilized by 3% (w/v) digito-
nin. Proteins with smaller size than rTAO in the solubilized
fraction (Fig. 2, lane 4) may not be proteolytic product of
rTAO because only one band was observed in Western blot
of this fraction by using monoclonal antibody against C-ter-
minal fragment of the enzyme, although a possibility that this
band is N-terminal part of rTAO can not be ruled out. After
digitonin-solubilization from the membrane of FN102/pTAO,
histidine-nickel a⁄nity chromatography was used to purify
rTAO. Fig. 3A shows a typical elution pro¢le of ubiquinol
oxidase activity during the puri¢cation of rTAO. The isolated
rTAO has a molecular mass of 34 kDa and possessed ubiqui-
nol oxidase activity (Fig. 3B). Highly puri¢ed enzyme ob-
tained by repuri¢cation with nickel chromatography was esti-
mated to be 90% pure by SDS^PAGE (Fig. 3C). We identi¢ed
a protein band with a molecular mass of 70 kDa in the West-
ern blot, even though SDS^PAGE was run under reducing
conditions (Fig. 3C). This may be a dimer of rTAO because
this band was recognized by monoclonal antibody against
TAO. Dimeric form of TAO in the Western blot was also
observed previously (Fig. 3 in [16]).
The speci¢c activity of the puri¢ed rTAO was quite high
compared to that of the enzymes partially puri¢ed from try-
panosome [16] and Sauromatum guttatum [23] mitochondria,
and always exceeded 40 Wmol/min/mg protein when quinol
oxidase was determined using 150 WM of ubiquinol-1 as sub-
strate. This value is about twice that of partially puri¢ed en-
zyme from Arum maculatum reported by Zhang et al. [25].
Table 1 summarizes the puri¢cation. More than seven-fold
puri¢cation was attained, and 3.1% of the activity was recov-
ered from the membrane of FN102/pTAO cells. These results
also show that digitonin is essential for keeping the enzyme in
an active form during the puri¢cation.
3.3. Properties of puri¢ed rTAO and the mechanism of
inhibition by ascofuranone
Once we had puri¢ed rTAO, we analyzed its enzymatic
properties. We found that the ubiquinol oxidase activity of
rTAO was cyanide-insensitive. Addition of 10 mM of cyanide
did not have any e¡ect on the ubiquinol oxidase activity of
rTAO. Table 2 summarizes the kinetic properties of TAO in
the mitochondria of T. brucei brucei, rTAO in the E. coli
membrane and puri¢ed rTAO. The Km values for ubiquinone
obtained from Lineweaver^Burk plot were almost identical
between mitochondrial enzyme and rTAO (Fig. 4A and Table
2). These ¢ndings suggest that puri¢ed rTAO retains the prop-
erties of native mitochondrial TAO.
We further examined the mechanism of inhibition by the
speci¢c TAO inhibitor ascofuranone. Using either T. brucei
brucei mitochondria or puri¢ed rTAO, ascofuranone was a
competitive inhibitor vs. ubiquinol shown by Lineweaver^
Burk plot (Fig. 4A). Then, result was analyzed by Dixon
plot, because only lower range of substrate concentrations
than Km could be assayed due to the low solubility of ubiqui-
none as discussed later (Fig. 4B). The analysis showed clearly
a competitive inhibition of quinol oxidase activity by ascofu-
ranone, indicating that the site of inhibition of ascofuranone
is the quinol binding domain of TAO. The Ki values obtained
from Dixon plot were almost identical between mitochondrial
and puri¢ed enzymes (Fig. 4B and Table 2). The competitive
inhibition of quinol oxidase activity by ascofuranone is not
surprising given that it and ubiquinol have similar ring struc-
tures (Fig. 1). The idea that the ring structure plays an im-
portant role in the inhibitory mechanism is further supported
by the fact that the inhibitory e¡ect of ascofuranone is dra-
matically reduced when its 4-OH group is changed to 4-O-
methoxycarbonylmethyl or 4-O-carboxymethyl [2].
Accurate analysis of kinetic property of the enzyme was
hampered by the high Km value for ubiquinone and its low
solubility. Because of hydrophobic isoprenoid chain of ubiqui-
nol-1, maximum concentration, which we were able to prepare
in the assay mixture, was 150^200 WM (about 20% of the Km
values). Therefore, apparent Km obtained here may be higher
than real Km values, although Vmax values obtained from
Lineweaver^Burk plot and Dixon plot were almost identical
(Fig. 4A,B).
This ¢nding of competitive inhibition contrasts with our
previous report that ascofuranone inhibits ubiquinol-depen-
dent oxygen uptake in a non-competitive manner [2]. One
possible reason may be low Ki value of ascofuranone. Inhib-
itor with Ki value of nM order tends to show non-competitive
kinetics even when it is competitive with respect to a given
substrate [26]. Another possible reason is that this apparent
contradiction may be due to the di¡erent assay systems used.
Speci¢cally, in the previous report, ubiquinol-dependent oxy-
Table 1
Puri¢cation of TAO by nickel ion chromatography
Fractions Protein Total activity Speci¢c activity Recovery
mg Wmol/min Wmol/min/mg protein %
Membrane 94.0 506 5.38 100
Digitonin extract 21.8 86.3 3.96 17.1
Nickel column (fractions 17^20) 0.378 15.7 41.5 3.10
Table 2
Kinetic parameters of TAO in E. coli FN102/pTAO cells and T. brucei brucei mitochondria
Sample Km for ubiquinol-1a Vmaxa Kib
WM Wmol/min/mg protein nM
T. brucei brucei mitochondria 625 0.77 1.40
E. coli FN102/pTAO membrane 714 10.5 1.29
Puri¢ed rTAO 662 240 1.69
aApparent values obtained from Lineweaver^Burk plots.
bValues obtained from Dixon plots.
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gen uptake was determined polarographically with an oxygen
electrode, while the present study utilized a spectrophotomet-
ric assay. The present result showing competitive inhibition is
much more reliable because ubiquinol concentration is di⁄-
cult to control in the polarographic assay due to adsorption to
the electrode and the assay chamber made by plastics. For
quinol oxidase measurement, spectrophotometric assay is rec-
ommendable rather than polarographic assay when the reac-
tion mixture contains hydrophobic substrates with low solu-
bility such as ubiquinol-1. Competitive inhibition of TAO in
mitochondria by ascofuranone was also observed when activ-
ity was measured by specrophotometric assay (Table 2). Sim-
ilar Ki values for inhibition by ascofuranone between mito-
chondrial enzyme and rTAO also suggest that puri¢ed rTAO
retains the properties of native mitochondrial TAO.
4. Conclusions
Although several groups have reported expression of AOX,
including TAO in E. coli, information on the speci¢c activity
and kinetics of the quinol oxidase activity has been unavail-
able because of the inability to produce a puri¢ed, active
enzyme [10,15,27,28]. The present study is the ¢rst report in
which AOX with high purity and quinol oxidase activity was
isolated. Three factors were critical for the puri¢cation of
rTAO: (i) overproduction of rTAO by the hemA-de¢cient mu-
tant; (ii) solubilization of active enzyme by digitonin; and (iii)
addition of an amino-terminal poly-histidine tag, enabling
one-step puri¢cation of the protein by nickel chromatography.
Isolation of pure enzyme enabled analysis of its kinetic prop-
erties and revealed the competitive inhibition by ascofura-
none. Furthermore, this puri¢ed rTAO will provide important
information about the cyanide-insensitive quinol oxidases be-
cause biochemical analysis of the AOXs, including prosthetic
groups, enzyme kinetic mechanisms and three-dimensional
structures has not been determined.
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